Abstract
across multiple cancer types. By doing so, we discover 16 "modules" of closely related lncRNAs that The functional themes of several modules reflected the cancer or normal tissue type specificity of their 145 lncRNAs ( Figure 2C , Table S5 ) [19] . As expected, neurological-associated ME5, ME10, and ME14 were 146 highly specific to brain cancers, and all 21 lncRNAs of stem cell associated ME13 were detected in 147 testicular germ cell tumours (TGCT), consistent with the notion that TGCT cells are derived from normal 148 germ cells with distinct stem cell characteristics [20] . ME6 was also highly specific to TGCT, and whilst7 there was no significant association with a stem cell signature, it included the lncRNA LINC-ROR, whichassociated ME9 and ME15, and extracellular matrix-associated ME7, ME12 and ME16, suggesting that 156 lncRNAs in these modules contribute to fundamental cellular processes common to most cancer types. 157
Detailed characterisation of the extracellular-associated modules 158
Given their pan-cancer expression, and current poor understanding of the role of lncRNAs in extracellular 159 processes, we were keen to dissect modules ME7, ME12 and ME16 further, and generate hypotheses on 160 their potential function in supporting tumour progression. 161
FOS/JUND transcription factor binding site enrichment in ME7 162
To establish whether lncRNAs in each of the extracellular modules share a common promoter, we 163 performed a de novo search for sequence motifs in regions 1000bp upstream of the lncRNA transcription 164 start site (TSS). Whilst there was no evidence for transcription factor binding enrichment in ME12 and 165 ME16, a top scoring motif achieving >95% similarity with FOS and JUND transcription factor binding 166 sites [23] was observed in 18/33 lncRNAs of ME7, ( Figure 3A ; Tables S6a-d ). There was no evidence 167 for enrichment of the FOS/JUND motif in the other 15 modules. 168
Underpinning this discovery, pro-module PC genes of ME7 were enriched for the binding site of 169 activator protein-1 (AP-1) (p=9.80E-07; Figure 3B ; Table S7 ), a transcription factor dimer of Jun and the 170 Fos family of basic leucine zipper domain proteins, with FOS-like antigen 1 (FOSL1) achieving the 171 highest PC-MA value of 0.036 (Table S3) . Moreover, strong binding of both c-Jun and c-Fos to the 172 promoter region of ME7 lncRNA, RP11-554I8.2 (also known as LINP1), has recently been confirmed in 173 triple negative breast cancer cell lines [24] . 174
Since c-Jun and c-Fos are known to co-operate with mothers against decapentaplegic homolog 175 comparison with [27] showed that the promoters of 13 of the top 20 ME7 pro-module genes could be 182 occupied by either SMAD2 or SMAD3. 183
TGFβ induces epithelial-mesenchymal transition (EMT) in tumours via activation of SMAD proteins 184
[28], which translocate into the nucleus and regulate transcription of TGFβ target genes [29] . 185 Furthermore, since SMADs have low affinity for DNA, it is crucial they interact with cofactors such as 186 AP-1 [30] to achieve target specificity. Exploring a potential link between ME7 and EMT induction via 187
TGFβ signalling, we observed significant enrichment (p=8. Determination of the tumour stromal specificity of ME12 and ME16 194 We noted that ME12 and ME16 shared a number of pro-module PC genes ( Figure 4A) We explored the potential stromal specificity of ME12 and ME16 further by using a novel approach to 200 generate a putative list of 300 stromal cell specific (SCS) lncRNAs frequently detected in stromal-201 containing clinical samples but not in pre-clinical models that consist almost exclusively of tumour cells 202 (Table S9a ; see Methods). Both ME12 and ME16 contained an abundance of SCS lncRNAs, achieving 203 60% (15/25) and 53.6% (7/11) overlap respectively (Table S9b) . By contrast, only 1/27 (3.7%) lncRNAs9 in ME7 were classed as SCS. These results provide strong in silico evidence that expression of lncRNAs 205 in ME12 and ME16 is specific to the tumour stroma. 206
Functional dissection of stromal-specific modules ME12 and ME16 207
To define more precise roles for the lncRNAs of ME12 and ME16, we identified 204 "ME12 specific" 208 and 226 "ME16-specific" PC genes that achieved a PC-MA fold difference>2.00 with the corresponding 209 PC gene in ME16 and ME12 respectively ( Figure 4B ; Table S10a Methods). Each lncRNA was classified as "pan-cancer up" or "pan-cancer down" if differential 219 expression was consistent across more than one cancer type, "single cancer up" or "single cancer down" 220 if observed in a single cancer type, or "both" if the lncRNA was differentially expressed in both 221 directions across different cancer types (Table S11a and 11b). 73% (19/26) of lncRNAs in ME12 were 222 classed as "pan-cancer down" or "single cancer down" ( Figure 4C , Table S11c ). These included the 223 known tumour suppressor maternally expressed gene 3 (MEG3) [35] , which was under-expressed in 4/14 224 cancers represented in our dataset. By contrast, only three lncRNAs in ME16 were classed as 225 differentially expressed, and none as either "pan-cancer down" or "single cancer down". 226
Interestingly, 39% (13/33) of lncRNAs in the third extracellular-associated module ME7 were classed 227 as either "pan-cancer up" or "single cancer up", with >70% of these over-expressed in head and neck 228 squamous cell carcinoma (HNSCC). This was concurrent with the strong association between ME7 and 229 FOSL1, which is consistently over-expressed in HNSCC [36] . 
Conclusion

275
In this study, we present the most comprehensive examination of the pan-cancer lncRNA expression 276 landscape to date. A key contribution is the development of a novel approach to integrate transcriptome 277 data across multiple cancers, allowing us to generate lncRNA-PC networks and de-convolute lncRNAs 278 into a small number of functionally coherent modules. By doing so, we provide some important insights 279 and hypotheses into the role of lncRNAs in cancer. Principally, lncRNAs can be grouped into just four 280 functional themes based on their associations with PC genes: immune, extracellular, transcription 281 regulation, and neurological. 282
Whilst a number of modules are clearly driven by the tissue specificity of their lncRNAs, several pan-283 cancer modules are identified, of which three may represent distinct lncRNA networks associated with 284 extracellular processes that regulate key events in tumour progression. Two of these modules are stromal12 specific, corresponding to a 26-lncRNA signature associated with a tumour suppressive 286 microenvironment, and 12 lncRNAs with a potential role in cancer fibroblast activation leading to poor 287 prognosis. The third module consists of a tumour-derived signature of 33 lncRNAs that may play a role 288 in inducing EMT through modulation of TGFβ signalling. Adding confidence to our approach, the 289 potential functional regulatory roles of two members of the putative lncRNA CAF signature were 290 validated by experimental modulation in fibroblasts. Interestingly, whilst reduction in TGF-β1-mediated 291 stress-fibre formation was observed for both lncRNAs, it reached statistical significance only for 292
AC093850.2 (also known as LINC01614). The nearest upstream neighbour of AC093850.2 is fibronectin, 293
a key component of CAF-derived ECM known to influence matrix remodelling associated with metastasis 294
[44]. Therefore, our findings could indicate a lncRNA-mediated control mechanism of fibroblast 295 differentiation via cis-regulation of fibronectin by AC093850.2. 296
Since reference to modules alone may mask subtle functional differences that exist between lncRNAs, 297 we encourage researchers to explore the individual lncRNA PC-MA profiles provided as supplementary 298 data (https://figshare.com/s/753cc0df15197b0b9572). Together with the modules, they provide a unique, 299 global compendium from which to generate novel hypotheses and motivate detailed functional studies on 300 lncRNA roles in cancer. 301
Methods
302
TCGA RNA-Seq data processing 303 Raw FASTQ sequence files for each solid tumour represented in TCGA were downloaded from the 304 Cancer Genomics Hub (CGHub; https://cghub.ucsc.edu/), and reads aligned to the human (GRCh38) 305 genome using StarAlign [45] with no more than three mismatches and only uniquely mapped reads 306 allowed. Reads whose ratio of mismatches to mapped length was greater than 0.10 were also discarded. 307
All other parameters were set to their defaults for unstranded alignment. To reduce possible biases 308 introduced by variable total read counts between samples, tumours achieving <20,000,000 mapped reads 309 were removed. The expression level, based on Fragments Per Kilobase per Million fragments mapped 310 (FPKM), of each gene present in the human (GRCh38) GENCODEv22 annotation file was estimated 311 using Cufflinks with library type defined as "fr-unstranded" and all other parameters set to defaults [46] .ignored, as well as genes whose largest transcript is less that 400bp due to potential over-estimation of 315 expression across transcripts less than the average fragment length. We also removed lncRNA and PClncRNAs. Note that a poly-A selection protocol was used for TCGA RNA-Seq, and so lncRNAs are 319 restricted to these species. Sequencing data for all TCGA cancer types used in this study were processed 320 using the same procedure. The number of tumours across each cancer type is given in Table S1 . 321
Pan-cancer estimation of the correlation between each lncRNA and PC gene 322
Visual inspection of the data indicates that a three-component mixture distribution is an appropriate 323 representation. The first two densities can be seen to decay exponentially away from the x and y axes and 324 the third distribution looks bivariate Gaussian ( Figure S2 ). We use the expectation maximisation (EM) 325 algorithm to estimate the parameters of our statistical mixture model. Since we are specifically interested 326 in the correlation coefficient of the bivariate Gaussian density, we estimate the separate parameters of the 327 bivariate Gaussian covariance matrix rather than the whole covariance matrix itself. To exploit the 328 convenience of using sufficient statistics for the parameters, we ensure that the mixture density is in the 329 exponential family. Data across 32 cancer types (indexed by c) is used in the maximum likelihood 330 estimation. The three-component mixture density likelihood over the 32 cancer types is: 331 
Then the EM updates are as follows: 345
Accounting for the uncertainty of the estimated pan-cancer correlation 348
Here ߩ ො expression signal is insufficient to calculate a correlation estimate, the cancer type is not consideredcorrelation cannot be estimated, and thus failure to calculate an MCA score for a specific PC gene. 355
Where this occurs for over 50% of the PC genes, the lncRNA is not considered further, resulting in 356 removal of a further 265 lncRNAs. Overall, 1833 lncRNAs have an MCA score for more than 50% of the 357 matrix using a soft thresholding power of 7 to which the MCA score correlation was raised to calculate 362 adjacency. To aid choice of soft thresholding power we used the "pickSoftThreshold" WGCNA function 363 with candidate powers 1-10, 12, 14, 16, 18 and 20. The power 7 was the lowest power for which the 364 scale-free topology fit index reached 0.95 ( Figure S3A , resulting in a network with mean connectivity of 365 5.94 ( Figure S3B ). Modules were then identified by average linkage hierarchical clustering of lncRNAs, 366 and modules identified in the resulting dendrogram by the Dynamic Hybrid tree cut using signed 367 topographical overlap matrix (TOM) and network types, a minimum module size of five, and a threshold 368 for merging high correlated modules of 0.25. All other parameters were set to their default values. 369
Signature enrichment analysis 370
Functional, cell type, transcription factor and disease type enrichment analyses were performed on each 371 set of pro-and anti-module PC genes using Toppgene [48] . Significant enrichments were defined as 372 those achieving False Discovery Rate less than 0.05 and signature overlap greater than two genes. 373
Differential expression between tumour and normal samples 374
RNA-Seq raw FASTQ sequence files for TCGA matched normal samples across 24 cancer types were 375 downloaded from CGHub, and gene expression estimates derived using the same procedure as for the 376 tumour samples. 10 cancer types comprised of <10 samples after filtering so were removed from further 377 analyses (Table S1) (Table S12) . 402 BAM files consisting of reads mapped to the human (GRCh37) genome were downloaded from the 403
CGHub for the 828 cell lines representing 19 solid cancer types (Table S13) Table   604 S1. 
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The first two densities decay exponentially away from the x-and y-axes and the third distribution is a clearly 636 separated bivariate Gaussian. 640 Table S1 . Number of TCGA patients contributing to this study across 32 cancer types.
641 Table S2 : Module assignment and correlation of lncRNA association score profiles with the eigen-lncs.
642 Table S3 : Eigen-lnc coefficients (PC-MA scores) contributed by each protein coding gene.
643 Table S4 : ToppGene functional enrichment in pro-module protein coding genes. 660 Table S12 : PC-MA scores of genes in a reactive stroma signature.
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661 Table S13 : Number of CCLE cell lines contributing to this study across 19 cancer types.
